Evidence map›Paper›PMID 25749296›Full record

ArticleActa biomaterialia2015

Enzymatic regulation of functional vascular networks using gelatin hydrogels.

Chia-Hui Chuang, Ruei-Zeng Lin, Han-Wen Tien, Ya-Chun Chu, Yen-Cheng Li, Juan M Melero-Martin, Ying-Chieh Chen

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Chia-Hui ChuangDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC.
Ruei-Zeng LinDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Han-Wen TienDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC.
Ya-Chun ChuDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC.
Yen-Cheng LiMaterial and Chemical Research Laboratories, Industrial Technology Research Institute, Hsinchu 31040, Taiwan, ROC.
Juan M Melero-MartinDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Ying-Chieh ChenDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC. Electronic address: yingchiehchen@gmail.com.
National Hsinchu University of Education · TWBoston Children's Hospital · USHarvard University · USIndustrial Technology Research Institute · TW

Funding

Vascular networks genetically engineered for protein drug deliveryR01HL128452 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M, WANG, BO · 2015 to 2024
$4.8M
Engineering vascularized tissue in vivo using postnatal progenitor cellsR00EB009096 · NIBIB · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2011 to 2013
$719k
Engineering vascularized tissue in vivo using postnatal progenitor cellsK99EB009096 · NIBIB · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2009 to 2010
$180k
NHLBI NIH HHS R01 HL128452NIBIB NIH HHS K99 EB009096NIBIB NIH HHS R00 EB009096NIBIB NIH HHS R00EB009096
6 · The paper itself

Abstract

To manufacture tissue engineering-based functional tissues, scaffold materials that can be sufficiently vascularized to mimic the functionality and complexity of native tissues are needed. Currently, vascular network bioengineering is largely carried out using natural hydrogels as embedding scaffolds, but most natural hydrogels have poor mechanical stability and durability, factors that critically limit their widespread use. In this study, we examined the suitability of gelatin-phenolic hydroxyl (gelatin-Ph) hydrogels that can be enzymatically crosslinked, allowing tuning of the storage modulus and the proteolytic degradation rate, for use as injectable hydrogels to support the human progenitor cell-based formation of a stable and mature vascular network. Porcine gelatin-Ph hydrogels were found to be cytocompatible with human blood-derived endothelial colony-forming cells and white adipose tissue-derived mesenchymal stem cells, resulting in >87% viability, and cell proliferation and spreading could be modulated by using hydrogels with different proteolytic degradability and stiffness. In addition, gelatin was extracted from mouse dermis and murine gelatin-Ph hydrogels were prepared. Importantly, implantation of human cell-laden porcine or murine gelatin-Ph hydrogels into immunodeficient mice resulted in the rapid formation of functional anastomoses between the bioengineered human vascular network and the mouse vasculature. Furthermore, the degree of enzymatic crosslinking of the gelatin-Ph hydrogels could be used to modulate cell behavior and the extent of vascular network formation in vivo. Our report details a technique for the synthesis of gelatin-Ph hydrogels from allogeneic or xenogeneic dermal skin and suggests that these hydrogels can be used for biomedical applications that require the formation of microvascular networks, including the development of complex engineered tissues.

Indexed as

Tissue ScaffoldsBiocompatible MaterialsCell ProliferationCells, CulturedCross-Linking ReagentsEndothelial CellsEquipment DesignEquipment Failure AnalysisGelatinHorseradish PeroxidaseHumansHydrogelsMaterials TestingMicrovesselsNeovascularization, PhysiologicPhenolsBiocompatible MaterialsCross-Linking ReagentsGelatinHorseradish PeroxidaseHydrogelsPhenolsGelatin hydrogelsIn vivoTissue engineeringVascular graftVascularization

Identifiers

PMID25749296
PMCPMC4589259
OpenAlexW1968501833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.